M, male; F, female ;AA, aplastic anemia; ALL, acute lymphoblastic
leukemia; AML, acute myeloblastic leukemia; FA, Fanconi anemia; HLH,
hemophagocytic lymphohistiocytosis; MDS, myelodysplastic syndrome; MPAL,
mixed-phenotype acute leukemia; MPS, mucopolysaccharidosis; MS, myeloid
sarcoma; HLA, human leukocyte antigen; Bu, busulfan; Cy,
cyclophosphamide; Flu, fludarabine; ATG, anti-thymocyte globulin; ALG,
anti-lymphocyte globulin; VP-16, etoposide; TBI, total body irradiation;
GVHD, graft-versus-host disease; CsA, cyclosporin A; MMF, mycophenolate
mofetil; MTX, methotrexate; FK506, tacrolimus; PTCy, post-transplant
cyclophosphamide; MNC, mononuclear cells.
Table 2 Clinical features of pediatric patients with TA-TMA